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Abstract
Leishmania amazonensis is one of the major etiological agents of the neglected, stigmatiz-
ing disease termed american cutaneous leishmaniasis (ACL). ACL is a zoonosis and
rodents are the main reservoirs. Most cases of ACL are reported in Brazil, Bolivia, Colom-
bia and Peru. The biological cycle of the parasite is digenetic because sand fly vectors
transmit the motile promastigote stage to the mammalian host dermis during blood meal
intakes. The amastigote stage survives within phagocytes of the mammalian host. The pur-
pose of this study is detection and identification of changes in protein abundance by 2DE/
MALDI-TOF/TOF at the main growth phases of L. amazonensis promastigotes in axenic
culture and the differentiation process that takes place simultaneously. The average num-
ber of proteins detected per gel is 202 and the non-redundant cumulative number is 339. Of
those, 63 are differentially abundant throughout growth and simultaneous differentiation of
L. amazonensis promastigotes. The main finding is that certain proteins involved in resis-
tance to nitrosative and oxidative stress are more abundant at the last stages of growth and
differentiation of cultured L. amazonensis promastigotes. These proteins are the arginase,
a light variant of the tryparedoxin peroxidase, the iron superoxide dismutase, the regulatory
subunit of the protein kinase A and a light HSP70 variant. These data taken together with
the decrease of the stress-inducible protein 1 levels are additional evidence supporting the
previously described pre-adaptative hypothesis, which consists of preparation in advance
towards the amastigote stage.
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Introduction
American cutaneous leishmaniasis (ACL) is caused by 15 species of the genus Leishmania
(Kinetoplastida: Trypanosomatidae), which includes species from the Leishmania and the
Viannia subgenera. The latter is also able to cause mucocutaneous (MCL) leishmaniasis. L. (L.)
amazonensis is one of the major etiological agents of ACL and it is grouped into the "L.mexi-
cana complex". The initial ACL lesions are crater-shaped and they become ulcerated in the cen-
ter with the progression of the disease. The species L.mexicana, L. pifanoi and L. amazonensis
are also able to cause an infrequent form of the disease termed anergic diffuse cutaneous leish-
maniasis (ADCL) [1], which is characterized by diffuse nodular lesions and total or partial
anergy. ACL and ADCL are not life threatening, as a difference with visceral leishmaniasis
(VL) caused by other species, but they are responsible for considerable morbidity.
According to theWHO epidemiological records, about 1.5 millon cases of CL are registered
worldwide anually. Most ACL cases are concentrated in Brazil, Bolivia, Colombia and Peru [2,
3]. A recent increase in the cases of leishmaniasis has been observedglobally, which may be
explained by many interrelated factors as scarce control, poverty, poor hygiene, migrations,
return to rural areas, penetration into the jungle, changes in ambient humidity, deforestation,
etc. ACL is a zoonosis and the major reservoirs are rodents when the etiological agents belong
to the L.mexicana complex [2].
The life cycle of the parasite involves an invertebrate host that injects the motile promasti-
gote stage of the parasite to the mammalian host when feeding from venules of the dermis. The
vector belongs to the genus Lutzomyia (Psychodidae: Phlebotominae) in the case of New
World species of the parasite like L. amazonensis. Promastigotes are engulfed by host phago-
cytes and differentiate to amastigotes. When a sand fly feeds from blood of an infectedmam-
mal, amastigotes are released from phagocytes, transform into undifferentiated (procyclic)
promastigotes and begin a developmental process from the procyclic to the more infective
metacyclic stage.
A remarkable number of trypanosomatid genome sequences were assembled and annotated
[4–6], which allowed for studying differential gene expression in different species, thus contrib-
uting to the knowledge about the biology of the parasite [7]. This is essential for future discov-
ery of drug targets and vaccine candidates. In the case of L. amazonensis, two-dimension
electrophoresis (2DE) maps of promastigotes were described [8, 9]. In another study, the effect
of culture passage and the resulting decrease of infectivity in the proteome profile of stationary
phase promastigotes were evaluated by the same approach [10]. Also, a transcriptome analysis
focused in the search of genes associated to antimony resistance was performed in promasti-
gotes at the mid-logarithmic phase of growth in axenic culture [11]. However, differential gene
expression throughout growth and development of the promastigote stage of L. amazonensis in
culture and within the sand fly gut has not been still explored. The aim of this study is compar-
ing different time points of growth of promastigotes in culture by 2DE and subsequent matrix-
assisted laser desorption-ionization tandem time-of-flightmass spectrometry (MALDI-
TOF/TOF).
Materials and Methods
Parasites
Promastigotes of the L. amazonensis strainMHOM/Br/79/María were kindly provided by
AlfredoToraño andMercedes Domínguez [12] and cultured at 27°C, pH 7.2 in liquidmedia
composed of RPMI 1640 supplemented with L-glutamine (Life Technologies, Carlsbad, CA),
10% heat inactivated fetal bovine serum (Lonza, Basel, Switzerland) and 100 μg/ml streptomycin–
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100 IU/ml penicillin (Life Technologies). The initial cell density was adjusted to 2 x 106 cells/ml
in all cultures and growth was registered daily at the light microscope using a Neubauer chamber.
Culture samples containing 108 promastigotes were obtained at the early-logarithmic,mid-loga-
rithmic, late-logarithmic and stationary phases.
Total protein extracts
Promastigotes (108 per sample) were harvested at 2,000 g for 10 min and washed once in PBS.
Then, the sediment was carefully resuspended in 150 μl lysis buffer (8.4 M urea, 2.4 M thiourea,
5% CHAPS, 50 mMDTT, 1% Triton X-100, 50 μg/ml DNase and Mini EDTA-free Protease
Inhibitor Cocktail according to the manufacturer’s instructions –Roche,Mannheim, Germany)
and immediately mixed by mild rotation at 4°C for 30 min. Then, the protein extracts were
centrifuged at 8,000g for 10 min. The supernatant was recovered, precipitated with methanol/
chloroform [13], dried at room temperature for 5 min and resuspended in 2X rehydration
buffer (7 M urea, 2 M thiourea, 4% CHAPS, 0.003% bromophenol blue). Quantification was
performedwith the RC DC protein assay kit (BioRad) following the manufacturer’s instruc-
tions and the results were compared with SDS-PAGE results as described [14].
Two-dimensional electrophoresis (2DE)
Fifty μg of total protein per sample were diluted to a final volume of 140 μl in 2X isoelectrofo-
cusing (IEF) buffer (18.2 M DTT and 0.5% IPG buffer solution pH 3–10, BioRad). Then, sam-
ples were subject to IEF on 7 cm IPG pH 3–10 non-linear gradient strips (BioRad) in a Protean
IEF Cell system (BioRad) following the manufacturer's instructions. Each run comprised seven
steps (50 V for 12h, 250 V for 1h, 500 V for 1h, 1000 V for 1h, 2000 V for 1h, linear ramp to
8000 V for 1h and 8000 V up to 3500 Vh), reaching more than 12,000 Vh in every one. Then,
the strips were run by 12% SDS-PAGE in a pre-cooledMiniProtean 3 DodecaCell system
(BioRad) at 0.5 W/gel for 30 min and then at 1.5 W. The run was stopped 5 min after the die-
front reached the bottom edge. The gels were stained with SYPRO Ruby (BioRad) and the gel
images were acquired with EXQuest Spot Cutter (BioRad) according to the manufacturer's
instructions.
The gel images were processed and analyzed with PDQuest 2D Advanced 8.0.1 software
(BioRad) according to the manufacturer's instructions. First, the images were cropped and
spots were detected automatically with the Spot Detection Parameter Wizard at a sensitivity
value of 3.5. Then, all detected spots were manually checked by observation of 3D density
graphs, single spot quantitation histograms and 2DE gel images. Normalization was performed
by the Total Quantity in Valid Spots algorithm. Normality was checked by the Kolmogorov-
Smirnov test and statistical inference of differential protein abundance was performed by the
Student's t-test at the 0.05 significance level. Reproducibility was assured by preparing three
independent biological replicate samples. However, all 2DE runs were performed simulta-
neously, which is essential for technical reproducibility across gels. For this purpose, all sam-
ples were stored at -80°C until use.
Protein identification by MALDI-TOF/TOF
After excision of the selected spots with EXQuest Spot Cutter (BioRad), they were digested
with trypsin and prepared for MALDI-TOF/TOFmass-spectrometry as described [14]. The
digests were deposited in OptiTOF™ Plates (Life Technologies). Each well contained a 0.8 μl
drop of peptidesmixed with 0.8 μl of 3 μg/μl α-cyano-4-hydroxycinnamic acid (Sigma). The
mixtures were allowed to dry at room temperature and run in an ABI 4800 MALDI-TOF/TOF
mass spectrometer (Life Technologies) in positive reflectormode at 25 kV for MS and 1 kV for
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MS/MS. The data obtained were analyzed with ABI 4000 Series Explorer software 3.6 (Life
Technologies). Peptide mass fingerprinting (PMF) and MS/MS spectra of fragment ions were
smoothed and corrected to the zero baseline using routines embedded in ABI 4000 Series
Explorer Software v3.6. Each PMF spectrumwas internally calibrated with the mass signals of
trypsin autolysis ions to reach a typical mass measurement accuracy< 25 ppm. Known trypsin
and keratin mass signals, as well as potential sodium and potassium adducts (+21 Da and + 39
Da) were removed from the peak list. Protein identifications were performedwith MASCOT
2.1 using Global Protein Server Explorer 4.9 (Life Technologies). The following search parame-
ters were introduced: enzyme, trypsin; allowedmissed cleavages, 1; carbamidomethyl cystein
as fixedmodification by treatment with iodoacetamide; variable modifications, oxidation of
methionine;mass tolerance was set to ± 50 ppm for precursors and to ± 0.3 Da for MS/MS
fragment ions. The confidence interval for protein identification was set to 95% (p< 0.05)
and only peptides with an individual ion score above the identity threshold (52) were consid-
ered correctly identified. The reference template for MASCOT identifications was the genome
sequence of L.mexicana (http://tritrypdb.org/common/downloads/release-9.0/LmexicanaMH
OMGT2001U1103/fasta/data/) because the genome of L. amazonensis has not been sequenced
yet and this species is included in the "L.mexicana complex". All data were also run against
against individual L. amazonensis sequences within the NCBInr database. The identifications
are available in the PRIDE repository of the ProteomeXchange Consortium [15] with the acce-
sion number PXD002939.
Evaluation of resistance to nitric oxide (NO) by the [3’-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] (MTT) assay
Logarithmic and stationary phase promastigotes were washed with PBS and at 26°C for 4 h at a
cell density of 106 in a final volume of 100 μl in the presence of different concentrations (1:2
serial dilutions from 16 to 0.25 mM) of NaNO2 (NO donor) in PBS pH 5.0. Next, suspensions
were centrifuged at 700g for 10 min and the sediments were resuspended in 100 μl PBS pH 7.0.
Then, 10 μl of 5 mg/mlMTTwere added and the cells were incubated at 25°C for 4 h. The reac-
tion was stopped and formazan solubilized by adding 100 μl of 0.4N HCl in 50% isopropanol.
Finally, A490nm was measured to assess formazan accumulation, which is related to viability
[16]. The differences were statistically assessed with the paired Student’s t-test from three bio-
logical replicates of the experiment.
Results and Discussion
2DE-MS/MS analysis of L. amazonensis promastigotes
Total protein was extracted from L. amazonensis axenic cultures of promastigotes at early-loga-
rithmic (day 2), mid-logarithmic (day 3), late-logarithmic (day 5) and stationary (day 7) phase
(Fig 1). Average protein concentrations (mg/ml) were: 4.4 ± 0.2 (day 2 promastigotes);
4.5 ± 0.4 (day 3); 4.4 ± 0.1 (day 5); 4.5 ± 0.2 (day 7). (Fig 2). The spots were automatically
detectedwith the Spot Detection Parameter Wizard. Sensitivity was adjusted to 3.5 in order to
filter out the non-identifiable faintest spots according to experimental setup with the mass
spectrometer. An average of 202 spots were detected per gel and the cumulative non-redundant
number is 339 (S1 Table). The cut-off ratio values were 1.7 for up-regulation and 0.6 for down-
regulation (1.7 and -1.7 fold changes), respectively (S1 Fig, S1 Table). Statistical significance
was inferred with the Student’s t test (p< 0.05) because the outcome of the Kolmogorov-Smir-
nov test was p = 0.318, 0.280 and 0.273 for the comparisons day3:day2, day5:day2 and day7:
day2, respectively. Ratios are relative to early-logarithmic phase promastigotes (day 2). Sixty
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three differentially expressed proteins out of 339 could be identified by MALDI-TOF/TOF (Fig
2, Table 1, S1 Table) against the TriTrypDB L.mexicana genome annotations. All selected pro-
teins were identified and the MASCOT score values were significant, except for one spot that
could not be identifiedwith the L.mexicana reference genome sequence but the NCBInr data-
base instead (Table 2, spot Lam1601, soluble promastigote surface antigen fragment PSA-31S,
part of the PSA-38S). In fact, this L. amazonensis gene had been previously characterized [17].
Random identification of constitutively expressed proteins was also performed (Table 2),
which occasionally allowed for retrieving additional information about relative expression in
different pathways (see below). In certain cases, different spots contain the same protein, which
may be due to protein processing, post-translational modifications or protein aggregation. In
the next sections, this has been cited as "protein variant". In principle, the nature of the varia-
tions is unknown but the 2DE-resolved variants could be separately analyzed and identified.
The comparison of experimental and/or predictedmolecular weight and isoelectricpoint pro-
vides insight (Table 3). For example, three variants of the protein LmxM.15.1160 were found.
Two of them present a similar MW but differ in the estimated pI value in 0.5 pH units, whereas
the MW of the third one is about 40% lower and the pI 8.5, which strongly suggests that a con-
siderable portion of the protein sequence has been removed during intracellular protein pro-
cessing. The most striking changes in experimentalMW and pI (Table 3) are discussed below
according to changes in relative abundance of variants of the same protein.
The differential gene expression results at the protein abundance level in the promastigote
differentiation process studied herein are compared below with expression profiles reported in
other species. Experimental variation between studies has been considered. In other cases, the
Fig 1. Growth curve of L. amazonensis promastigotes. Total protein samples were prepared and
quantified at day 2 (early logarithmic phase), day 3 (mid logarithmic phase), day 5 (late logarithmic phase/
early stationary phase) and day 7 (stationary phase).
doi:10.1371/journal.pone.0164344.g001
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information is complemented with reported data about the differentiation process of promasti-
gotes to amastigotes.
Differential protein abundance in L. amazonensis promastigotes
Regulation of gene expression. Proteins involved in translation and post-transcriptional
regulation of gene expression, play a key role in the biology of trypanosomatids because these
organisms lack most transcriptional regulationmechanisms (reviewed in [18]). The abundance
of some of them changes in the growth and differentiation process of L. amazonensis promasti-
gotes. First, three variants of the translation elongation factor 2 (EF2) are up-regulated in mid-
logarithmic with respect to early-logarithmic phase promastigotes, as well as two different
DEAD/DEAHRNA helicases and the alanine-tRNA synthetase (Table 1). One EF2 variant is
considerably lighter and slightly more basic (60.3 KDa, pI 6.9) than the others (Table 3), which
suggests that it is partially proteolyzed during processing. The two other variants may have
been post-translationally modified, according to the differences in the theoreticalMW values
(Tables 1 and 3). A heavier variant of the EF2 is constitutively expressed (Tables 2 and 3). This
Fig 2. Examples of 2DE of total protein extracts of L. amazonensis promastigotes. (A) Early logarithmic (day 2) and (B) stationary phase (day
7). IEF was performed in a non-linear 3–10 pH interval. (C) 3D density graphs of spots Lam2801, Lam3501, Lam6102 and Lam7004 obtained with PD
Quest software.
doi:10.1371/journal.pone.0164344.g002
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Table 1. Differential gene expression regulation in L. amazonensis promastigotes. The MW and pI values provided were estimated by the 2DE analy-
sis software PD Quest. Theoretical values can be obtained from the L. mexicana LmxM genome databank within TriTrypDB by introducing the gene Ids. pro-
vided in this table.
Spot TriTrypDB ID Protein MASCOT
score
(p < 0.05)
MW
(KDa)
pI Day3:Day2
(p < 0.05)
Day5:Day2
(p < 0.05)
Day7:Day2
(p < 0.05)
Lam 102 LmxM.34.4470 Hypothetical protein, conserved 300 23.74 3.3 0.51 (-1.96) 0.39 (-2.56) 0.56 (-1.78)
Lam1101 LmxM.04.0770/
60
Unspecified product 96/89 23.16 4.0 0.5 (-2.00) 0.31 (-3.22)
Lam1103 LmxM.14.0190 Hypothetical protein, conserved 512 25.18 4.7 0.57 (-1.75)
Lam1204 LmxM.36.3210 14-3-3 protein 1, putative 442 27.66 4.6 0.36 (-2.78)
Lam1205 LmxM.08.1230 Beta tubulin 640 30.55 4.8 2.55
Lam1503 LmxM.25.0750 Protein phosphatase, putative 512 44.71 4.6 0.53 (-1.89) 0.56 (-1.78)
Lam1702 LmxM.13.0160 Protein kinase A regulatory subunit,
putative
70 66.63 4.7 24.28
Lam2001 LmxM.15.0281/75 Ribonucleoprotein p18, mitochondrial
precursor, putative
247/247 17.44 5.2 0.34 (-2.94)
Lam2202 LmxM.13.0300 Unspecified product 206 27.99 5.1 40.22
Lam2304 LmxM.14.0310 Proteasome alpha 3 subunit 187 31.14 5.3 1.86
Lam2401 LmxM.25.1710 Pyruvate dehydrogenase E1 beta subunit,
putative
133 38.28 5.2 0.27 (-3.7) 0.17 (-5.89)
Lam2801 LmxM.32.0312/
14/16
Heat shock protein 83–1 614/614/614 91.86 5.0 3.03
Lam3102 LmxM.23.0040 Peroxidoxin 589 22.38 5.5 0.36 (-2.78)
Lam3201 LmxM.34.1480 Arginase (ARG) 67 27.65 5.5 18.08 28.89
Lam3301 LmxM.34.1540 Rieske iron-sulfur protein, mitochondrial
precursor, putative (RISP)
105 32.87 5.5 0.38 (-2.63)
Lam3501 LmxM.28.2770/80 Heat-shock protein hsp70, putative 234/165 44.50 5.4 24.06
Lam3505 LmxM.07.0640 Hypothetical protein, conserved 320 40.57 5.5 0.09 (-11.1)
Lam3601 LmxM.14.1160 Enolase 586 49.17 5.6 0.48 (-2.08) 0.49 (-2.04)
Lam3701 LmxM.36.2020/30 Chaperonin hsp60, mitochondrial
precursor
820/356 67.83 5.3 0.01 (-100)
Lam3704 LmxM.36.2030/20 Chaperonin hsp60 mitochondrial precursor 700 66.34 5.5 0.21 (-4.76) 0.49 (-2.04)
Lam3705 LmxM.36.6650 2,3-bisphosphoglycerate-independent
phosphoglycerate mutase
304 68.99 5.5 60.01
Lam3801 LmxM.28.2770/80 Heat-shock protein hsp70, putative 990/211 73.81 5.4 0.44 (-2.27)
Lam3803 LmxM.29.2490/
60/70
Heat shock 70-related protein 1,
mitochondrial precursor, putative
874/727/726 76.87 5.5 0.32 (-3.12)
Lam3901 LmxM.22.1540 Alanyl-tRNA synthetase, putative 376 112.48 5.6 1.83
Lam4001 LmxM.23.0200 Endoribonuclease L-PSP (pb5), putative 360 12.93 5.7 1.76
Lam4002 LmxM.34.1300 Ubiquitin-conjugating enzyme E2, putative 135 12.16 5.5 0.46 (-2.17)
Lam4401 LmxM.23.0110 Mannose-1-phosphate guanyltransferase
(GDP-MP)
344 39.32 5.6 2.63
Lam4403 LmxM.30.2250 3,2-trans-enoyl-CoA isomerase,
mitochondrial precursor, putative
251 37.59 5.7 0.59 (-1.70)
Lam5001 LmxM.15.1160/40 Tryparedoxin peroxidase 200/75 12.88 5.9 30.53
Lam5002 LmxM.20.1280 Calpain-like cysteine peptidase, Clan CA,
family C2, putative
324 13.92 6.1 0.02 (-50.00) 0.01
(-100.00)
Lam5103 LmxM.15.1160/40 Tryparedoxin peroxidase 216/82 21.97 6.0 47.02
Lam5302 LmxM.28.2740 Activated protein kinase C receptor
(LACK)
510 32.08 6.1 0.51 (-1.96) 0.27 (-3.70) 0.25 (-4)
Lam5501 LmxM.06.0370 Glutamine synthetase, putative 262 41.01 5.9 0.38 (-2.63) 0.54 (-1.85)
Lam5502 LmxM.32.2300 UDP-glucose-4’-epimerase, putative 354 43.91 5.9 0.55 (-1.82)
(Continued )
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constitutive variant may contain additional post-translational modifications, probably glyco-
sylation regarding to the increase in MW (Table 3). The increase in abundance of the EF2 vari-
ants (Tables 1 and 2) suggests changes in translational regulation at an intermediate point of
growth and differentiation. The EF2 was described to be an immunostimulatory protein in L.
donovani [19], but the importance of this protein for differentiating promastigotes may rely
more directly in regulation of translation rather than preparation in advance for colonization
Table 1. (Continued)
Spot TriTrypDB ID Protein MASCOT
score
(p < 0.05)
MW
(KDa)
pI Day3:Day2
(p < 0.05)
Day5:Day2
(p < 0.05)
Day7:Day2
(p < 0.05)
Lam5504 LmxM.06.0880 Acyl-coenzyme A dehydrogenase, putative 146 44.02 6.1 14.91
Lam5801 LmxM.30.0010 5-methyltetrahydropteroyltriglutamate-
homocysteine methyltransferase, putative
(MET6)
575 92.78 5.9 3.49
Lam5804 LmxM.36.0180 Elongation factor 2 560 107.45 6.1 1.76 0.42 (-2.38) 0.41 (-2.43)
Lam5901 LmxM.36.0180 Elongation factor 2 449 107.63 6.0 2.35
Lam6102 LmxM.15.1160/40 Tryparedoxin peroxidase 305/163 21.94 6.5 0.58 (-1.72)
Lam6403 LmxM.36.4170 Oxidoreductase, putative 194 36.13 6.3 0.03 (-33.3)
Lam6701 LmxM.34.3860 T-complex protein 1, eta subunit, putative 402 69.50 6.2 0.06(-16.67)
Lam6702 LmxM.36.2660 Dihydrolipoamide acetyltransferase 128 55.74 6.3 0.45 (-2.22)
Lam6703 LmxM.11.0630/20 Aminopeptidase, putative,metallo-
peptidase, Clan MF, Family M17/
aminopeptidase, putative
325/186 61.94 6.3 3.33 2.72
Lam6704 LmxM.31.3310 Dihydrolipoamide dehydrogenase 565 55.19 6.4 0.57 (-1.75)
Lam6801 LmxM.28.2770 Heat-shock protein hsp70, putative 190 73.71 6.2 0.31 (-3.22)
Lam6806 LmxM.31.2951/50 Nucleoside diphosphate kinase b 553/553 88.79 6.8 0.09 (-11.1) 0.06 (-16.67)
Lam7003 LmxM.31.2951/50 Nucleoside diphosphate kinase b 544/544 13.19 7.5 0.31 (-3.22)
Lam7004 LmxM.31.1820/30 Iron superoxide dismutase, putative 476/265 19.91 7.6 1.75
Lam7603 LmxM.34.1380 Mitochondrial processing peptidase, beta
subunit, putative, metallo-peptidase, Clan
ME, family M16
522 52.84 7.0 40.36
Lam7605 LmxM.34.1380 Mitochondrial processing peptidase, beta
subunit, putative, metallo-peptidase, Clan
ME, family M16
681 50.37 7.5 1.76
Lam7701 LmxM.34.3860 T-complex protein 1, eta subunit, putative 427 63.99 6.8 0.4 (-2.5) 0.52 (-1.92)
Lam7702 LmxM.36.0180 Elongation factor 2 300 60.30 6.9 3.34
Lam7703 LmxM.36.0070 Stress-inducible protein STI1 homolog 318 65.49 7.4 0.5 (-2.00) 0.24 (-4.17) 0.59 (-1.70)
Lam7801 LmxM.18.0510 Aconitase, putative 502 103.24 7.0 0.43 (-2.32)
Lam8003 LmxM.06.0120 Cyclophilin 321 13.18 9.2 0.51 (-1.96) 0.48 (-2.08)
Lam8005 LmxM.26.1380 Prefoldin-like protein/Cyclophilin, putative 125/106 21.02 9.5 30.56
Lam8101 LmxM.24.0850 Triose phosphate isomerase 621 23.26 9.1 0.44 (-2.27) 0.43 (-2.32)
Lam8102 LmxM.36.0070 Stress-inducible protein STI1 homolog 347 25.49 9.4 0.43 (-2.32)
Lam8201 LmxM.24.1980 Hypothetical protein, conserved 404 30.12 9.2 15.15
Lam8501 LmxM.31.0840 Hypothetical protein, conserved 188 42.92 8.2 0.36 (-2.78) 0.33 (-3.03)
Lam8701 LmxM.25.1120 Aldehyde dehydrogenase, mitochondrial
precursor
497 54.99 8.0 1.77
Lam8703 LmxM.07.0340 ATP-dependent DEAD/H RNA helicase,
putative
201 67.09 9.4 6.04
Lam8706 LmxM.03.0200/
24.0770
Delta1-pyrroline-5-carboxylate
dehydrogenase, putative/Malic enzyme,
putative
181/163 59.28 9.1 20.4
doi:10.1371/journal.pone.0164344.t001
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of the host cell within the mammalian host (see pre-adaptative hypothesis below). An alterna-
tive possibility could be the decrease of the steady-state levels in case the immune response elic-
ited by the protein leads to progression of the disease.
Another protein involved in gene expression regulation is the endoribonuclease L-PSP
(pb5), which was found to be down-regulated in amastigotes of species causative of cutaneous
(L.mexicana, L.major) and visceral (L. donovani, L. infantum) leishmaniasis [20–24]. How-
ever, information about differential abundance of this protein throughout the promastigote
growth and differentiation process is not available so far. In the case of L. amazonensis, this
endoribonuclease is over-expressed in stationary phase promastigotes, therefore at the end of
the differentiation process (Table 1).
Protein folding. The heat shock proteins HSP70 and HSP83-1 were described to be abun-
dant and constitutive throughout the main stages of the life cycle of Leishmania spp. [25, 26].
Table 2. Constitutively expressed proteins in L. amazonensis promastigotes. The MW and pI values provided were estimated by the 2DE analysis
software PD Quest. Theoretical values can be obtained from the L. mexicana LmxM genome databank within TriTrypDB by introducing the gene Ids. pro-
vided in this table.
Spot TriTrypDB ID Protein MASCOT score (p < 0.05) MW (KDa) pI
Lam1601 ACY70938 (NCBI Id.) Soluble promastigote surface antigen PSA-31S 221 74.38 4.4
Lam2502 LmxM.32.0312/14/16 Heat shock protein 83–1 288/288/288 61.34 5.1
Lam2601 LmxM.36.6940 Protein disulfide isomerase 395 73.85 5.5
Lam2803 LmxM.28.1200 Glucose-regulated protein 78, putative 611 105.47 5.2
Lam2804 LmxM.36.1370 Transitional endoplasmic reticulum ATPase, putative,
valosin-containing protein homolog
185 147.73 5.7
Lam3001 LmxM.08_29.1160 Tryparedoxin 1, putative (TXN1) 228 13.20 5.4
Lam3802 LmxM.29.1760/50 Paraflagellar rod protein 1D, putative 312/312 127.12 5.4
Lam4601 LmxM.32.2540 Carboxypeptidase, putative,metallo-peptidase, Clan MA(E),
Family M32
457 79.14 5.7
Lam4801 LmxM.26.1570 Thimet oligopeptidase, putative,metallo-peptidase, Clan MA
(E), Family M3
247 98.15 5.7
Lam4803 LmxM.28.2770/20 Heat-shock protein HSP70, putative 199 97.64 5.8
Lam5503 LmxM.01.0770 Unspecified product 315 73.92 6.0
Lam5506 LmxM.36.2950 Succinyl-CoA ligase (GDP-forming) beta chain, putative 748 54.02 6.2
Lam5702 LmxM.27.1260 T-complex protein 1, beta subunit, putative 279 80.04 6.1
Lam5803 LmxM.36.0180 Elongation factor 2 136 124.23 6.0
Lam6402 LmxM.25.1610 Hypothetical protein, conserved 79 62.25 6.4
Lam6705 LmxM.27.1220 Hypothetical protein, conserved 145 78.46 6.6
Lam7503 LmxM.10.0290 Isocitrate dehydrogenase (NADP), mitochondrial precursor,
putative
283 65.21 7.5
Lam7602 LmxM.18.0670 Citrate synthase, putative 273/270 74.91 6.8
Lam7604 LmxM.21.0340 Mitochondrial processing peptidase alpha subunit, putative,
metallo-peptidase, Clan ME, Family M16
223 74.26 7.2
Lam8001 LmxM.15.1160/40 Tryparedoxin peroxidase 248/102 22.46 8.5
Lam8103 LmxM.21.0850 Xanthine phosphoribosyltransferase 319 24.12 9.4
Lam8203 LmxM.36.5120/10 40S ribosomal protein SA, putative 354/255 34.03 9.4
Lam8403 LmxM.36.1260 Fructose-1,6-bisphosphate aldolase 458 66.15 9.5
Lam8601 LmxM.32.2340 Succinyl-CoA:3-ketoacid coenzyme A transferase,
mitochondrial precursor, putative
712 68.41 8.2
Lam9201 LmxM.02.0460 Voltage-dependent anion-selective channel, putative
(VDAC)
298 36.34 9.5
Lam9301 LmxM.25.2130/40 Succinyl-CoA synthetase alpha subunit, putative 319/319 47.70 9.5
Lam9401 LmxM.29.2980 Glyceraldehyde-3-phosphate dehydrogenase, glycosomal 458 48.53 9.5
doi:10.1371/journal.pone.0164344.t002
Proteome Profiling of Leishmania amazonensis Promastigotes
PLOS ONE | DOI:10.1371/journal.pone.0164344 October 24, 2016 9 / 20
Differential expression in the promastigote stage of L. infantum was not detected at the tran-
script and protein levels [14, 20]. In the case of L. amazonensis, distinct variants of both chaper-
ones are constitutively or differentially expressed in promastigotes throughout growth and
differentiation (Tables 1 and 2). Two HSP70 (LmxM.28.2770) variants of the sameMW but
different estimated pI (5.4 and 6.2) are less abundant at late-logarithmic phase (Tables 1 and
3). The HSP70-related protein 1 (HSP70-rel1), encoded by a different gene (LmxM29.2490), is
slightly heavier (Table 3) and its relative abundance is analogous, whereas a lighter variant of
the LmxM.28.2770HSP70 (44.5 KDa) of estimated pI around the theoretical value (5.2) is
highly up-regulated (24-fold) in stationary phase promastigotes (Tables 1 and 3). Finally, a
heavier variant (97.6 KDa) is constitutive (Tables 2 and 3). Therefore, alternation of HSP70
variants originated by protein processing or post-translational modifications is observed at the
last stages of the growth and differentiation process of L. amazonensis promastigotes. Simulta-
neously, the chaperonin HSP60 is down-regulated (late-logarithmic phase), whereas the differ-
entially regulated variants of the HSP83 are down-regulated at mid-logarithmic phase, an
earlier point of growth and differentiation. According to our results, the overall HSP70 levels
increase in the ongoing of differentiation of promastigotes considering all variants together. As
HSP70 proteins of L. infantum and L. donovani were described to be immunostimulatory [19,
27], they may be involved in colonization of the mammalian host phagocytesby differentiated
promastigotes, though it may lead to susceptibility or resistance of the host depending on the
type of immune response elicited.
According to previous data, the stress-inducible protein 1 homolog (STI1) is constitutively
expressed in the developmental process of stationary phase promastigotes to amastigotes in the
case of L. infantum [28] but no information is available about growth and development of pro-
mastigotes. In the case of L. amazonensis, the STI1 is down-regulated at late logarithmic phase
(Table 1), simultaneously to some HSPs mentioned above.
Two variants of the η subunit of the T-complex protein 1 (TCP1η) are down-regulated in
late logarithmic phase promastigotes (Table 1), whereas the TCP1β subunit is constitutively
expressed (Table 2). Therefore, the down-regulation of the TCP1η, the STI1 and the HSPs
mentioned above is simultaneous and takes place at one of the final stages of growth and differ-
entiation of L. amazonensis promastigotes in culture. The exact function of the TCP complex is
Table 3. Remarkable examples of protein variants. Comparison of experimental (Exp) and predicted theoretical (P) MW and pI.
TriTryp Id. Protein ExpMW PMW ExppI PpI
LmxM.15.1160 TryP 12.9 22.2 8.5 6.7
LmxM.15.1160 TryP 22.0 22.2 6.0 6.7
LmxM.15.1160 TryP 21.9 22.2 6.5 6.7
LmxM.28.2770 HSP70 44.5 71.2 5.4 5.2
LmxM.28.2770 HSP70 73.8 71.2 5.4 5.2
LmxM.28.2770 HSP70 73.7 71.2 6.2 5.2
LmxM.28.2770 HSP70 97.6 71.2 5.8 5.2
LmxM.29.2490 HSP70-rel1 76.9 72.5 5.5 5.7
LmxM.31.2951 NDKb 88.79 16.7 6.8 7.5
LmxM.31.2951 NDKb 13.2 16.7 7.5 7.5
LmxM.34.1380 M16 peptidase 52.8 54.6 7.0 7.1
LmxM.34.1380 M16 peptidase 50.4 54.6 7.5 7.1
LmxM.36.0180 EF2 107.4 94.1 6.1 6.0
LmxM.36.0180 EF2 107.6 94.1 6.0 6.0
LmxM.36.0180 EF2 60.3 94.1 6.9 6.0
doi:10.1371/journal.pone.0164344.t003
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not known in Leishmania spp., although it has been suggested that the TCP1γ subunit may
participate in maintaining the structural dynamics of the cytoskeleton [29]. Changes in cell
morphology throughout promastigote differentiation and flagellar movement demand contin-
uous re-organization of the cytoskeleton. Differential expression of the TCP1η has not been
reported in L. infantum promastigotes differentiating in culture so far, although the encoding
gene is up-regulated at the transcript level in metacyclic promastigotes isolated from the sand
fly anterior midgut [30].
A cyclophilin variant is down-regulated in mid-logarithmic phase L. amazonensis promasti-
gotes, whereas another variant is constitutively expressed. Cyclophilins are able to prevent
aggregation of adenosine kinase domain-containing proteins [31, 32] like nucleoside diphos-
phate kinases (NDK). Two NDKb variants encoded by the same gene but very different in MW
(presumably due to processing) are up-regulated at the beginning of growth and differentiation
of promastigotes (early-logarithmic phase) (Tables 1 and 3). Up-regulation of the NDKb at the
transcript level in procyclic L. infantum promastigotes [33] agrees with the profile found in L.
amazonensis. The NDKs are involved in nucleotide biosynthetic processes, which may occur
preferentially at the initial stages of growth and differentiation of promastigotes as suggested
by the results. The 14-3-3 protein 1 relative abundance profile is the same as for the NDKb in
L. amazonensis promastigotes. The exact functions of 14-3-3 proteins are unknown, although
they have been related to many cellular processes. An intrinsic NDK activity has been associ-
ated to these proteins in general [34] and antiapoptotic properties of the L. donovani orthologs
have been reported [35]. In fact, the 14-3-3 protein is able to prolong the lifespan of the
infected host phagocyte. However, given the multiple functions of this protein, the implications
of its increased levels at the beginning of promastigote growth and differentiation are not
known so far. The decrease of Cph may cause an increase in aggregation of NDKb and 14-3-3,
which may be a clue to explain their decrease at an earlier stage.
Proteolysis. Two components of the ubiquitin-proteasome system are differentially abun-
dant throughout growth and differentiation of L. amazonensis promastigotes: the ubiquitin-
conjugating enzyme E2 (UbqC-E2) is down-regulated in late-logarithmic phase, whereas the
proteasome α-3 subunit is up-regulated in stationary phase promastigotes (Table 1). None of
them have been detected in differential gene expression analysis during development of pro-
mastigotes of any Leishmania species in culture so far. However, it has been described that the
the E2 steady-state transcript levels are higher in cultured promastigotes than in promastigotes
obtained from the sand fly gut [30, 36]. The 14-3-3 protein is associated to other components
of the proteasome [37]. As mentioned above, the abundance of this protein decreases at the last
stages of growth and development of L. amazonensis promastigotes (late-logarithmic phase
promastigotes), which is simultaneous to the decrease of the UbqC-E2.
Other proteases of unknown function are up-regulated in mid-logarithmic phase of growth
and development of L. amazonensis promastigotes: two mitochondrial protein peptidase vari-
ants, a metal-dependent aminoexopeptidase of the M17 family and two variants of a mitochon-
drial processing peptidase of the M16 family that present similar MW and pI analogous to the
theoretical value (Table 3). Last, the calpain LmxM.20.1280 is down-regulated in late-logarith-
mic phase promastigotes, whereas the paralog (LinJ.20.1230) was found to be up-regulated in
L. infantum metacyclic promastigotes [33]. The physiological meaning of all these changes in
proteasome components and proteases of unknown function is not known so far, although
those changes at a mid time point of promastigote differentiaton suggest that they are involved
in degradation of self proteins during this process.
Signaling. The protein kinase A (PKA) of L. amazonensis was described to be involved in
autophagy [38, 39], which is a critical process in promastigote differentiation. This is in agree-
ment with 24-fold increase of the regulatory subunit (rPKA) in stationary phase promastigotes
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of this species (Table 1). The rPKA is also up-regulated at the transcript level at the same
growth phase of L. infantum promastigotes [20]. Therefore, these data point to an increase of
abundance of the rPKA upon growth and differentiation of the promastigote stage, which may
be critical for survival.
The receptor of the activated protein kinase C (RACK) of Leishmania spp. (LACK) is up-
regulated in early-logarithmic phase promastigotes in L. amazonensis (Table 1). Constitutive
expression throughout growth of L. infantum promastigotes has been reported [40]. The motile
stage of Crithidia fasciculata, a monogenetic trypanosomatid that does not infect mammals in
its life cycle, also increases the levels of the RACK orthologueCACK in early logarithmic phase
[41] like L. amazonensis, according to 2DE-MALDI-TOF/TOF results obtained by the same
procedure. The LACK antigen is able to protect partially against canine leishmaniasis when the
encoding gene is administered in a mammalian expression plasmid vector either containing
antibiotic resistance genes or alternative selectionmarkers [42]. This protein is located in the
particulate fraction of the cytoplasm near the plasma membrane and it is up-regulated in L.
infantum amastigotes [40]. RACK proteins belong to theWD40 repeat family. In particular,
LACK is able to bind sequences present in certain proteins involved in DNA replication and
RNA synthesis and the β chain of the MHC-II. RACKs are able to translocate PKCs to the
required intracellular locations [24] in order to participate in certain signal transduction path-
ways that have been characterized in mammalian cells [25]. The current knowledge on signal
transduction pathways is still reduced in trypanosomatids.However, progress has beenmade
with particular proteins. For example, at least one of the rPKA functions could be determined
(autophagy, involved in metacyclogenesis) and it is known that LACK is a good vaccine candi-
date [42]. The signaling proteins 14-3-3 and putative protein phosphatase in Table 1 are more
abundant in early logarithmic phase. The 14-3-3 protein is also involved in protein folding. As
mentioned above, antiapoptotic function able to prolong the lifespan of the infectedmacro-
phage has been also described [35].
Catabolism and biosynthesis of surfacemolecules. Glycolysis is less active in amastigotes
than in promastigotes [43]. The opposite has been observed for β-oxidation of fatty acids. Most
glycolytic enzymes are compartmentalized in the glycosome and some of them have been con-
sidered as potential drug targets [44–46]. Thiol groups of glycolytic enzymes are modified
under nitrosative stress in Escherichia coli andMycobacterium tuberculosis, leading to an
appropriate conformational state of the protein that somehow allows for resistance [47, 48].
These findings suggest an interesting hypothetical association between steady-state levels of
glycolytic enzymes in the appropriate conformational state and resistance to NO. M. tuberculo-
sis and certain invasive E. coli strains are facultative intracellular pathogens, whereas the amas-
tigote of Leishmania spp. is an obligate intracellular stage. Promastigotes are also able to
survive in the presence of NO. On these grounds, we propose a hypothetical association
between differential abundance of glycolytic enzymes and resistance to nitric oxide (see discus-
sion about nitric oxide resistance below). However, this has not been experimentally tested.
The triose phosphate isomerase (TPI), the enolase and the bisphosphoglycerate-independent
phosphoglycerate mutase (PGMBPI) are differentially regulated in L. amazonensis promasti-
gotes (Table 1), whereas the glyceraldehyde-3-phosphate dehydrogenase (gGAPDH) is consti-
tutively expressed (Table 2). Constitutive expression of the gGAPDHwas also described in the
differentiation process of L. infantum promastigotes to amastigotes [28]. The abundance of the
TPI, a potential vaccine candidate [49], decreases in mid-logarithmic phase promastigotes,
whereas the PGMBPI is up-regulated at late-logarithmic phase. The PGMBPI was reported to be
down-regulated in L. infantum and L. donovani amastigotes [20, 23, 24, 50] at the transcript
and protein levels, respectively. Additionally, this protein is considered a promising drug target
candidate [51]. Differential expression of the TPI and the PGMBPI has not been detected across
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promastigote growth and differentiation of these visceral leishmaniasis-causative species in
other studies. The enolase is down-regulated at the final stages of growth and differentiation of
L. amazonensis (late-logarithmic phase) (Fig 3), which is analogous at the transcript level
(over-expressed in metacyclics) in the case of L. infantum [33]. This protein is down-regulated
in the amastigote stage of L.mexicana, L. donovani and L. infantum [21, 23, 24, 33]. The
expression profile in L. infantum stationary phase metacyclic promastigotes is comparable at
the transcript level [33].
Three components of the pyruvate dehydrogenase complex (PDC), namely the E1β subunit,
dihydrolipoamide dehydrogenase (DHLDH) and dihydrolipoamide acetyltransferase
(DHLAT), are significantly up-regulated in early-logarithmic phase promastigotes (Fig 3,
Fig 3. Differential abundance of proteins involved in L. amazonensis metabolism. Constitutively expressed and differentially regulated proteins
that participate in glycolysis, the Krebs cycle, amino acid metabolism and β-oxidation of fatty acids are depicted. Colour legend for up-regulation:
green, day 2 (lag/early log); blue, day 3 (log); orange, day 5 (late log); red, day 7 (stat). The constitutively expressed proteins experimentally detected
throughout the promastigote growth curve are highlighted in violet. Abbreviations not detailed in the text: ALD, fructose-1,6-bisphosphate aldolase;
ECH, enoyl-CoA hydratase/isomerase; FMR, fumarase; MET6, methyltetrahydropteroyltriglutamate-homocysteine methyltransferase; MDH, malate
dehydrogenase; PGK, phosphoglycerate kinase; PK, pyruvate kinase; SDH, succinate dehydrogenase.
doi:10.1371/journal.pone.0164344.g003
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Table 1). The aconitase is the only differentially abundant enzyme of the Krebs cycle found.
This protein is over-expressed at the beginning of growth and differentiation of promastigotes
(in early-logarithmic phase), like the PDC components mentioned above. On the opposite, the
citrate synthase (CitS), isocitrate dehydrogenase (ICDH), succinyl-CoA synthetase α subunit
(SCS) and GDP-forming succinyl-CoA ligase β chain (SCL) are constitutively expressed (Fig 3,
Table 2). The Rieske iron sulfur precursor (RISP) is a protein involved in the electron transport
chain. RISP abundance decreases in late-logarithmic phase promastigotes, when growth and
differentiation are at an advanced stage. Krebs cycle and iron-sulfur cluster-dependent
enzymes have been associated to susceptibility to NO by growth inhibition depending on the
redox state of sulfhydryl groups in pathogenic bacteria [52, 53].
In summary, the differentially abundant glycolytic enzymes TPI and enolase, the DHLDH
and DHLAT components of the PDC and the electron transport chain protein RISP are down-
regulated in the final stages of growth and differentiation of promastigotes, except for the
increase of PGMBPI. These changes suggest higher demand of energy during the first stages of
promastigote development and might be somehow associated to nitric oxide resistance, as pro-
posed above. On the opposite, the acyl-CoAdehydrogenase, involved in β-oxidation of fatty
acids, is up-regulated in stationary phase promastigotes (Fig 3, Table 1), suggesting alternation
in the energy source at this stage.
The GDP-mannose pyrophosphorylase (GDP-MP) is up-regulated in late-logarithmic
phase promastigotes, which is in agreement with a previous observation in L. infantum pro-
mastigotes by the same approach [14]. The GDP-MP is essential for virulence of promastigotes
of L.mexicana [54], a species closely related to L. amazonensis. This enzyme is involved in bio-
synthesis of the lipophosphoglycan (LPG), the glycosylinositol phospholipids (GIPLs) and
other glycoconjugates characteristic of the surface of these parasites. The up-regulation of the
GDP-MP in late-logarithmic phase promastigotes suggests that higher amounts of these sur-
face molecules are synthesized when the end of growth and differentiation of promastigotes
approaches.
Up-regulation of proteins involved in resistance and survival at the last
stages of growth and development of L. amazonensis promastigotes
Trypanothione system. A processed protein variant (12.9 KDa, pI8.5) of the tryparedoxin
peroxidase (TryP) is constitutively expressed throughout the growth curve of L. amazonensis
promastigotes, whereas two heavier variants of estimated experimentalMW and pI close to the
theoretical values (22.0 KDa, pI6.0) are differentially abundant (Fig 4, Tables 1 and 3). One of
the TryP heavy variants is up-regulated at day 3, whereas the other one is down-regulated at
the same time point. The TryP light variant is highly up-regulated (>30-fold) in stationary
phase promastigotes (day 7). In the case of L. infantum, the TryP decreases in amastigotes com-
pared to promastigotes [28] but there are no available data about relative abundance during
growth and differentiation process of amastigotes to date. The complex expression profiles of
different TryP variants in L. amazonensis promastigotes (Fig 4) has not been found in Old
World Leishmania species such as L.major or L. infantum so far and the enzyme was reported
to be constitutively expressed in both species [20, 55], whereas the non-pathogenic trypanoso-
matid C. fasciculata differentially regulates the TryP across growth and differentiation of the
motile choanomastigote stage [41]. In addition to cellular detoxification of reactive oxygen
species, the TryP has been involved in other processes such signaling proliferation and differ-
entiation [56]. The complex expression pattern of different variants found in L. amazonensis
promastigotes (Fig 4) suggests that the TryP is especially important throughout the growth and
differentiation process studied herein.
Proteome Profiling of Leishmania amazonensis Promastigotes
PLOS ONE | DOI:10.1371/journal.pone.0164344 October 24, 2016 14 / 20
The iron superoxide dismutase (Fe-SOD) is over-expressed in L. amazonensis and in C. fas-
ciculata. This protein initiates elimination of the superoxide anion by conversion to hydrogen
peroxide. The Fe-SOD is up-regulated in L. amazonensis late logarithmic phase promastigotes
(day 5). The TryP is able to reduce this substrate thanks to the assistance of the tryparedoxin
(TXN1), the trypanothione (T[S]2/T[SH]2) and the NADPH-dependent enzyme trypanothione
reductase (TryR). The TryR has not been identified between the selected spots of this analysis
and the TXN1 is among the constitutively expressed ones (Table 2).
Arginase. The arginase is a manganese-dependent enzyme that participates in the urea
cycle by hydrolyzing L-arginine into urea and ornithine. These products are able to induce the
alternative macrophage activation pathway [57]. The ARG of the host phagocytic cell competes
with the inducible nitric oxide synthase (iNOS) for the substrate L-arginine [58]. For these rea-
sons, parasite clearance is more effectivewhen low levels of host ARG are expressed. The ARG
is also annotated in the genomes of the Leishmania species, thus contributing to decrease the
levels of NO synthesis by the iNOS of the host cell through substrate competence. This enzyme
is essential for infectivity, proliferation and virulence of the parasite [59, 60]. 2DE-MALDI-
TOF/TOF analysis has revealed high ARG levels (29-fold) in L. amazonensis stationary phase
promastigotes. L. infantum promastigotes overexpress the ARG in amastigotes with respect to
stationary phase promastigotes [28]. A possible explanation for these findings combined is
preparation in advance for differentiation to the amastigote stage and survival within the pha-
golysosome of the host cell. This statement is called pre-adaptation hypothesis and has been
previously supported [20, 61–63]. The MTT test has confirmed that L. amazonensis stationary
phase promastigotes are more resistant to NO than logarithmic phase promastigotes (Fig 5).
Therefore, NO resistance increases in the ongoing of growth and development of promasti-
gotes in culture.
Ornithine is an essential precursor in polyamine biosynthesis [54, 55]. This pathway is
essential for the biosynthesis of trypanothione because this molecule consists of two glutathi-
one residues coupled through spermidine. Consequently, arginase up-regulationmight be indi-
rectly related to the TryP differential expression profile found (Fig 4).
Synopsis of differentially abundant proteins involved in survival and resistance.
Decreased abundance of a variant of the STI1 chaperone simultaneous to the increase of the
levels of the ARG, HSP70, TryP, Fe-SOD (stress-resistance proteins) and rPKA (indicative of
differentiation) has been found when growth and differentiation of L. amazonensis promasti-
gotes is complete. These changes, especially ARG up-regulation, may be linked to the increased
Fig 4. Differential abundance of proteins involved in redox homeostasis. The FE-SOD participates in ROS processing providing hydrogen
peroxide, which is then reduced by the TryP with the assistance of the TXN1, trypanithione and TryR. TryP differential expression pattern is complex
through the promastigote growth curve of L. amazonensis. A light TryP variant is up-regulated in stationary phase promastigotes. A heavier TryP
variant is down-regulated at day 3 and another one up-regulated simultaneously. Finally, a fourth variant is constitutively expressed during
promastigote growth. Colour legend for up-regulation: green, day 2 (lag/early log); blue, day 3 (log); orange, day 5 (late log); red, day 7 (stat). The
constitutively expressed proteins experimentally detected throughout the promastigote growth curve are highlighted in violet.
doi:10.1371/journal.pone.0164344.g004
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ability of differentiated promastigotes to resist NO with respect to the non-differentiated,
which is in agreement with the pre-adaptation hypothesis towards survival within the host
phagocyte and may explain unsuccessful clearance by the immune system. In addition, higher
levels of the GDP-ManP have been observed at an advanced growth phase, which probably
leads to increased amounts of glycoconjugates in differentiated promastigotes.
Conclusions
2DE-MS/MS has revealed that promastigotes of the NewWorld species L. amazonensis, respon-
sible for ACL, up-regulate proteins involved in survival and resistance throughout growth and
development in culture: the TryP and the Fe-SOD, involved in defense against oxidative dam-
age; the ARG, involved in nitrosative stress resistance within the phagocytic host cell, which is
up-regulated in stationary phase promastigotes, thus supporting the pre-adaptative hypothesis;
the immunostimulatory protein HSP 70, involved in protein folding; and the rPKA, involved in
signaling and autophagy, thus related with metacyclogenesis. The LACK antigen is down-regu-
lated throughout growth and simultaneous development of promastigotes in this species causa-
tive of ACL, whereas it was reported to be constitutively expressed in the VL agent L. infantum.
The down-regulation of the STI1 and the up-regulation of proteins involved in resistance and
survival (ARG, HSP70, Fe-SOD, TryP and rPKA) in fully grown and differentiated promasti-
gotes suggest the pre-adaptative hypothesis, also proposed for other Leishmania species.
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S1 Fig. Scatter plot of differential protein abundance in L. amazonensispromastigotes.
(PPTX)
Fig 5. Resistance to NO of logarithmic and stationary phase promastigotes of L. amazonensis. The MTT assay was performed to compare the
ability to resist increasing concentrations of NaNO2 by logarithmic and stationary phase promastigotes of L. amazonensis. Three biological replicates
of the experiment were performed and the differences, contrasted by the paired t-test, were significant at all NaNO2 concentrations tested
(p*<0.001).
doi:10.1371/journal.pone.0164344.g005
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